Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison for propofol ED50 during hysteroscopic surgery
ChiCTR2000033220Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and propofol in None (5 arms), sponsored by Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Target-controlled infusion concentration of propofol and response to hysteroscopic cervical dilatation. Planned start May 2020; status: not yet recruiting.
02
Drugs
dexmedetomidinepropofol
Beyond the preview
Go deeper on ChiCTR2000033220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033220.